[Erythema migrans arciforme et palpabile (T-cell pseudolymphoma)].
A 65-year-old man with recurrent erythema migrans arciforme et palpabile (EMAP) is reported. EMAP is characterized as a T-cell pseudolymphoma, the cell populations of which are composed of T-helper- and T-suppressor cells in a ratio of 2:1. EMAP can therefore not be differentiated immunohistologically from the lymphocytic infiltration of Jessner-Kanof.
Lohrisch
I
I
Hautklinik, der Städtischen Kliniken Kassel.
Alexandrakis
E
E
Maywurm
H
H
Petres
J
J
D000368:Aged; D001402:B-Lymphocytes / Q000473:pathology; D014408:Biomarkers, Tumor / Q000032:analysis; D004730:Endothelium, Vascular / Q000473:pathology; D004890:Erythema / Q000473:pathology*; D006801:Humans; D007124:Immunoenzyme Techniques; D008223:Lymphoma / Q000473:pathology*; D008297:Male; D012867:Skin / Q000473:pathology; D012878:Skin Neoplasms / Q000473:pathology*; D013601:T-Lymphocytes / Q000473:pathology*
D014408:Biomarkers, Tumor
Erythema migrans arciforme et palpabile (T-Zell-Pseudolymphom).